Skip to content
Wenlo
Sign in
← Markets

Regeneron Pharmaceuticals, Inc.

George L Sing (Director) sells REGN shares

4REGNFiled Nov 18, 2026, 4:13 PM ET· Period Nov 16, 2026

AI-generated summary

Director George L Sing sold 2,000 shares of common stock in open-market transactions between November 16, 2026, and November 17, 2026, at an average price of $958.97 for a total value of $1,917,945.02. Following these transactions, the reporting person directly held 23,147 shares.

Key facts

Insider
George L Sing · Director
DateTransactionSharesPriceValueHeld afterOwnership
Nov 16, 2026S · open-market saleFootnotes F1−1,000$960.26$960,260.0024,147Direct
Nov 17, 2026S · open-market sale−176$956.96$168,424.9623,971Direct
Nov 17, 2026S · open-market saleFootnotes F2−359$957.49$343,738.9123,612Direct
Nov 17, 2026S · open-market saleFootnotes F3−465$958.11$445,521.1523,147Direct
Footnotes
  1. F1 Represents volume-weighted average price of sales of 1,000 shares of Company stock on November 16, 2026 at prices ranging from $960.00 to $960.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  2. F2 Represents volume-weighted average price of sales of 359 shares of Company stock on November 17, 2026 at prices ranging from $957.24 to $957.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
  3. F3 Represents volume-weighted average price of sales of 465 shares of Company stock on November 17, 2026 at prices ranging from $958.01 to $958.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.

More REGN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.